Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(E)-nonenal and 4-oxo-2-(E)-nonenal

Chemical Research in Toxicology

Volumn 16, Issue 7, 2003, Pages 901-911

  Liu, Zhongfa ^a   Minkler, Paul E ^b   Sayre, Lawrence M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 4 OXO 2 NONENAL; APOMYOGLOBIN; CHYMOTRYPSIN; MYOGLOBIN; SODIUM BOROHYDRIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; LIPID PEROXIDATION; MASS SPECTROMETRY; METHYLATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN MODIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STOICHIOMETRY;

EID: 0013222143     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0300030     Document Type: Article

References (49)

1. Spiteller, G. (2001) Lipid peroxidation in aging and age-dependent diseases. Exp. Gerontol. 36, 1425-1457.
2. Blasig, I. E., Grune, T., Schonheit, K., Rohde, E., Jakstadt, M., Haseloff, R. F., and Siems, W. G. (1995) 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am. J. Physiol. 269, H14-H22.
3. Lucas, D. T., and Szweda, L. I. (1998) Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc. Natl. Acad. Sci. U.S.A. 95, 510-514.
4. Eaton, P., Li, J. M., Hearse, D. J., and Shattock, M. J. (1999) Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am. J. Physiol. 276, H935-H943.
5. Chen, J., Henderson, G. I., and Freeman, G. L. (2001) Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J. Mol. Cell. Cardiol. 33, 1919-1927.
6. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11, 81-128.
7. Jurgens, G., Lang, J., and Esterbauer, H. (1986) Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim. Biophys. Acta 875, 103-114.
8. Steinbrecher, U. P., Witztum, J. L., Parthasarathy, S., and Steinberg, D. (1987) Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Atherosclerosis 7, 135-143.
9. Schauenstein, E., Taufer, M., Esterbauer, H., Kylianek, A., and Seelich, T. (1971) Reaction of protein SH-group with 4-hydroxy-2-nonenal. Monatsh. Chem. 102, 517-529.
10. Uchida, K., and Stadtman, E. R. (1992) Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. U.S.A. 89, 4544-4548.
11. Nadkarni, D. V., and Sayre, L. M. (1995) Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8, 284-291.
12. Sayre, L. M., Arora, P. K., Iyer, R. S., and Salomon, R. G. (1993) Pyrrole formation from 4-hydroxynonenal and primary amines. Chem. Res. Toxicol. 6, 19-22.
13. Sayre, L. M., Sha, W., Xu, G., Kaur, K., Nadkarni, D., Subbana-gounder, G., and Salomon, R. G. (1996) Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 9, 1194-1201.
14. Salomon, R. G., Kaur, K., Podrez, E., Hoff, H. F., Krushinsky, A. V., and Sayre, L. M. (2000) HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques. Chem. Res. Toxicol. 13, 557-564.
15. Uchida, K., and Stadtman, E. R. (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reaction. J. Biol. Chem. 268, 6388-6393.
16. Cohn, J. A., Tsai, L., Friguet, B., and Szweda, L. I. (1996) Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress. Arch. Biochem. Biophys. 328, 158-164.
17. Xu, G., and Sayre, L. M. (1998) Structural characterization of a 4-hydroxy-2-alkenal-derived fluorophore that contributes to lipoperoxidation-dependent protein cross-linking in aging and degenerative disease. Chem. Res. Toxicol. 11, 247-251.
18. Itakura, K., Osawa, T., and Uchida, K. (1998) Structure of a fluorescent compound formed from 4-hydroxy-2-nonenal and Na-hippuryllysine: a model for fluorophores derived from protein modifications by lipid peroxidation. J. Org. Chem. 63, 185-187.
19. Tsai, L., Szweda, P. A., Vinogradova, O., and Szweda, L. I. (1998) Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proc. Natl. Acad. Sci. U.S.A. 95, 7975-7980.
20. Xu, G., Liu, Y., and Sayre, L. M. (1999) Independent synthesis, solution behavior, and studies on the mechanism of formation of a primary amine-derived fluorophore representing cross-linking of proteins by (E)-4-hydroxy-2-nonenal. J. Org. Chem. 64, 5732-5745.
21. Lee, S. H., and Blair, I. A. (2000) Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem. Res. Toxicol. 13, 698-702.
22. Spiteller, P., Kern, W., Reiner, J., and Spiteller, G. (2001) Aldehydic lipid peroxidation products derived from linoleic acid. Biochim. Biophys. Acta 1531, 188-208.
23. Doorn, J. A., and Petersen, D. R. (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 15, 1445-1450.
24. Zhang, W.-H., Liu, J., Xu, G., Yuan, Q., and Sayre, L. M. (2003) Model studies on protein side-chain modification by 4-oxo-2-nonenal. Chem. Res. Toxicol. 16, 512-523.
25. Uchida, K., Toyokuni, S., Nishikawa, K., Kawakishi, S., Oda, H., Hiai, H., and Stadtman, E. R. (1994) Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry 33, 12487-12494.
26. Waeg, G., Dimsity, G., and Esterbauer, H. (1996) Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radical Res. 25, 149-159.
27. Itakura, K., Oya-Ito, T., Osawa, T., Yamada, S., Toyokuni, S., Shibata, N., Kobayashi, M., and Uchida, K. (2000) Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore. FEBS Lett. 473, 249-253.
28. Xu, G., Liu, Y., and Sayre, L. M. (2000) Polyclonal antibodies to a fluorescent 4-hydroxy-2-nonenal (HNE)-derived lysine-lysine cross-link: characterization and application to HNE-treated protein and in vitro oxidized low-density lipoprotein. Chem. Res. Toxicol. 13, 406-413.
29. Sayre, L. M., Zelasko, D. A., Harris, P. L., Perry, G., Salomon, R. G., and Smith, M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097.
30. Zainal, T. A., Weindruch, R., Szweda, L. I., and Oberley, T. D. (1999) Localization of 4-hydroxy-2-nonenal-modified proteins in kidney following iron overload. Free Radical Biol. Med. 26, 1181-1193.
31. Takeda, A., Smith, M. A., Avila, J., Nunomura, A., Siedlak, S. L., Zhu, X., Perry, G., and Sayre, L. M. (2000) In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J. Neurochem. 75, 1234-1241.
32. Oberley, T. D. (2002) Ultrastructural localization and relative quantification of 4-hydroxynonenal-modified proteins in tissues and cell compartments. Methods Enzymol. 352, 373-377.
33. Wataya, T., Nunomura, A., Smith, M. A., Siedlak, S. L., Harris, P. L., Shimohama, S., Szweda, L. I., Kaminski, M. A., Avila, J., Price, D. L., Cleveland, D. W., Sayre, L. M., and Perry, G. (2002) High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J. Biol. Chem. 277, 4644-4648.
34. Bolgar, M. S., Yang, C. Y., and Gaskell, S. J. (1996) First direct evidence for lipid/protein conjugation in oxidized human low-density lipoprotein. J. Biol. Chem. 271, 27999-28001.
35. Bolgar, M. S., and Gaskell, S. J. (1996) Determination of the sites of 4-hydroxy-2-nonenal adduction to protein by electrospray tandem mass spectrometry. Anal. Chem. 68, 2325-2330.
36. Bruenner, B. A., Jones, A. D., and German, J. B. (1995) Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry. Chem. Res. Toxicol. 8, 552-559.
37. Raquena, J. R., Fu, M. X., Ahmed, M. U., Jenkins, A. J., Lyons, T. J., Baynes, J. W., and Thorpe, S. R. (1997) Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem. J. 322, 317-325.
38. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Improved methods for building protein models in electron-density maps and the location of errors in these models. Acta Crystallogr. A47, 110-119.
39. Sailey, S. (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D50, 760-776.
40. Jentoft, N., and Dearborn, D. (1979) Labeling of proteins by reductive methylation using sodium cyanoborohydride. J. Biol. Chem. 254, 4359-4365.
41. Wang, F., and Tang, X. (1996) Conformational heterogeneity of stability of apomyoglobin studied by hydrogen/deuterium exchange and electrospray ionization mass spectrometry. Biochemistry 35, 4069-4078.
42. Eckenhoff, R. G., Pidikiti, R., and Reddy, K. S. (2001) Anesthetic stabilization of protein intermediates: myoglobin and halothane. Biochemistry 40, 10819-10824.
43. Evans, S. V., and Brayer, G. D. (1990) High-resolution study of the three-dimensional structure of horse heart metmyoglobin. J. Mol. Biol. 213, 885-897.
44. Roepstorff, P., and Fohlman, J. (1984) Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass Spectrom. 11, 601.
45. Maurus, R., Bogumil, R., Nguyen, N. T., Mauk, A. G., and Brayer, G. (1998) Structural and spectroscopic studies of azide complexes of horse heart myoglobin and the His-64 → Thr variant. Biochem. J. 332, 67-74.
46. Glocker, M. O., Borchers, C., Fiedler, W., Suckau, D., and Przybylski, M. (1994) Molecular characterization of surface topology in protein tertiary structures by amino-acylation and mass spectrometric peptide mapping. Bioconjugate Chem. 5, 583-590.
47. Suckau, D., Mak, M., and Przybylski, M. (1992) Protein surface topology-probing by selective chemical modification and mass spectrometric peptide mapping. Proc. Natl. Acad. Sci. U.S.A. 89, 5630-5634.
48. SCC lysine residues. Identification of lysines involved in the interaction with adrenodoxin. Biochim. Biophys. Acta 996, 247-253.
49. Chen, L.-J., Hecht, S. S., and Peterson, L. A. (1997) Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol. 10, 866-874.